Unrelated to SDC-180123 Oct 2025 07:11
This has to be good news for Sareum?
The adverse findings occurred predominantly in control group animals and are unrelated to SDC-1801. We are already in discussions with several Contract Research Organisations to restart the study as quickly as possible, and our focus remains firmly on completing the Phase 2-enabling package.